Author:
Antonuzzo Lorenzo,Messerini Luca,Comin Camilla,Meoni Giulia,Lucherini Elisa,Di Costanzo Francesco
Reference59 articles.
1. Yalcin S, Oyan B, Bayraktar Y (2007) Current medical treatment of pancreatic neuroendocrine tumors. Hepatogastroenterology 54: 278–84
2. Ehehalt F, Saeger HD, Schmidt CM, Grutzman R (2009) Neuroendocrine tumors of the pancreas. Oncologist 14: 454–67
3. Yao JC, Hassan M, Phan A et al (2008) One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35, 825 cases in the United States. J Clin Oncol 26: 3063–72
4. Vortmeyer AO, Huang S, Lubensky I, Zhuang Z (2004) Non-islet origin of pancreatic islet cell tumors. J Clin Endocrinol Metab 89: 1934–1938
5. Burnik FS, Yalcin S (2009) NF-kappa gene polymorphism in NET. Chemotherapy 2009. Chemotherapy 55: 381–5